IART INTEGRA LIFESCIENCES HOLDINGS CORP
Last updated: May 11, 2026
Execution Consistency
Did the company actually spend money buying back stock in 3+ of the last 4 quarters?
Bought back stock in 2/4 quarters. Q3 2025: $0M, Q3 2024: $125M, Q2 2024: $0M, Q1 2024: $150M
Execution Acceleration
Is the most recent quarter's buyback spend more than 15% above the trailing average?
Latest quarter $0M vs trailing avg $92M (-100%)
Buyback vs FCF
What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.
Negative FCF ($-172M), buybacks not supported by cash flow
Buyback Intensity
How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.
Repurchased 5,200,000 shares = 6.7% of 77,796,903 outstanding (annualized)
Insider Buying
Are officers and directors buying stock with their own money on the open market?
1 open-market purchase by GRAVES JEFFREY A
- GRAVES JEFFREY A () bought 9,000 shares at $11.35 on 2025-11-05
Insider-Buyback Convergence
Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.
Company buybacks in 2 quarters but insufficient insider buying
Insider Net Direction
Over the last 90 days, are insiders net buyers or net sellers on the open market?
Insiders bought $0M, sold $0M in the last 90 days (net buying)
Red Flag
Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.
No buyback-insider divergence detected